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Summary
The primary purpose of this study is to analyse the costs related to childhood
obesity (CO) with reference to different models of healthcare systems. A system-
atic review of the economic impact of CO on healthcare systems was conducted
by searching the main electronic scientific databases. Cost-of-illness (COI) analy-
ses of children aged under 18 years who had been diagnosed as overweight or
obese published up to July 2010 were considered. Short- and long-term conse-
quences of CO were taken into account. In order to appraise the quality of the
included studies, the British Medical Journal referees’ checklist was used. About
3,844 COI analyses were initially found and 10 were finally considered in the
current review: two studies referred to Beveridge and eight referred to Voluntary
health insurance models. No studies have been conducted within a Bismarck
model. Six studies considered in-patient costs, four studies estimated outpatient
and primary care costs and seven studies considered pharmaceutical costs. The
average quality of the included analyses was medium. The analysis confirmed the
significance of CO related costs and the heterogeneity among available studies,
which made it impossible to compare the different healthcare models.
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Introduction
Childhood obesity (CO) is one of the main public health
challenges of the 21st century (1). Excess weight and
obesity are among the most important public health issues
in developed countries (2). Lifestyle factors such as seden-
tary behaviour and hypercaloric food consumption have
led to dramatic increases in weight and body mass index
(BMI) (3), and CO has become a worldwide epidemic that
governments must face.
Current literature shows that being overweight or obese
during childhood and adolescence increases the risk of
developing several medical conditions (i.e. diabetes melli-
tus, hypertension, cardiovascular diseases, respiratory
ailments, depression, orthopaedic problems and main
cancers) (4). Worldwide estimates currently identify 18
million overweight children (5). The number of overweight
adolescents has tripled since 1980 and the prevalence
of obesity in younger children has more than doubled
(6). Approximately 10–30% of European children aged
7–11 years and 25% of European adolescents are over-
weight or obese (7). Studies have shown that being over-
weight or obese in childhood and adolescence has adverse
consequences such as premature mortality and physical
morbidity in adulthood (8).
CO has been demonstrated to have important social and
economic consequences (9), so it is necessary to assess its
economic burden. The economic consequences of CO are
typically categorized as direct, such as medical costs, and
indirect, such as school/work absenteeism (10). In the USA,
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the direct costs of CO include annual drug prescriptions,
emergency room visits and in-patient and outpatient costs.
Costs related to outpatient care in the USA in 2002–2005
were $14.1 billion (11) while in-patient costs were $237.6
million (12). The estimated annual cost of treating obesity-
related illness in adults in the USA amounted to $147
billion by 2008 (13). In almost all healthcare systems,
above all in those providing universal coverage and guar-
anteeing the health status in the population, decision-
makers need, in an era of scarcity of resources and fiscal
constraint, more evidence-based tools to be able to effec-
tively allocate funds for prevention and therapy.
The primary purpose of this study is to analyse
CO-related healthcare costs for different models of health-
care systems by investigating a possible relationship
between their magnitude and alternative healthcare
systems. A secondary purpose is to provide a quality
appraisal of the reviewed studies.
Methods
A systematic review of the economic impact of CO on
healthcare systems, according to methods provided by the
Task Force on Community Preventive Services (TFCPS),
was conducted (14). A literature search was performed
using the following electronic databases: Cochrane Library,
Database of Abstracts of Reviews of Effects, Cumulative
Index to Nursing and Allied Health Literature, EconLit,
Scopus, Health Technology Assessment Database,
Medline, National Health Service Economic Evalua-
tion Database (NHS EED) (http://www.crd.york.ac.uk/
CRDWeb/AboutNHSEED.asp), Health Business, Psyco
Info and Google Scholar. Each search engine was scanned
by means of a specific search string that combines a
database-specific mix of subject headings and text words
starting from the Medline search strategy (summarized in
Box 1).
Furthermore, scientific articles were found using the
Medline ‘related articles’ algorithm and reference lists of
eligible studies.
The following inclusion criteria were used.
• Cost-of-illness (COI) analyses published up to July
2010 and written in English, German, French or Spanish
were considered. COI analyses focused on children aged
under 18 years with a diagnosis of being overweight or
obese (BMI  85th percentile) were included (15).
• Incidence-based COI analyses that estimated lifetime
costs of CO for newly diagnosed cases were considered, as
well as prevalence-based analyses that included all medical
and morbidity costs. Both short- and long-term CO-related
consequences were taken into account.
• COI analyses reporting results of economic data for
direct medical costs were considered.
Assessment of the eligibility of the studies and data
abstraction was independently conducted by four couples
of reviewers (SB, AGdB; SC, MLS; FP, AM; WR, MAV).
Each pair consisted of a health economist and a medical
doctor.
Studies were selected according to the following criteria
• analysis of titles and abstracts;
• collection of the full text of potentially relevant
studies;
• cross-linking of studies retrieved from different data-
bases in order to find and remove duplicate articles;
• analysis of the full text in order to ensure that studies
met eligibility criteria.
Data were extracted using a checklist adapted from the
‘Economic Evaluation Abstraction Form’ provided by the
TFCPS (14).For each selected study, two teams of reviewers
(SB, AGdB, AM, FP; MLS, SC, MAV, WR) independently
assessed the methodological quality. The British Medical
Journal referees’ checklist developed by Drummond and
Jefferson (16) was used in order to appraise the quality of
the COI analyses included in the review. As only COI
analyses were included in our review, items that character-
ized full economic evaluations (Table 1) were not included.
To investigate the relationship between CO healthcare
costs and alternative healthcare systems, each study was
Box 1 Medline search strategy
The following algorithm for a systematic search was
developed:
(((((((((((((indirect cost*)) OR (*direct cost*)) OR
(medical cost*)) OR (economic*)) OR (economic
burden))) OR (payment)) OR (expen*))) OR
(((((((((‘Cost-Benefit Analysis’[Mesh] OR ‘Cost of
Illness’[Mesh]) OR ‘Healthcare Costs’[Mesh]) OR
‘Cost Savings’[Mesh]) OR (‘Costs and Cost
Analysis’[Mesh] OR ‘Hospital Costs’[Mesh] OR ‘Cost
Allocation’[Mesh])) OR ‘Cost Control’[Mesh]) OR
‘Delivery of Health Care/economics’[Mesh]) OR
‘Hospitalization/economics’[Mesh])) OR ((((((indirect
cost*)) OR (*direct cost*)) OR (medical cost*)) OR
(economic*)) OR (economic burden))))) AND
((((‘Obesity’[Mesh] OR ‘Overweight’[Mesh]) OR
‘Body Mass Index’[Mesh])) OR ((((fatness)) OR (over-
weight*)) OR (obes*)))) AND (((((((‘Adolescent’[Mesh]
OR ‘Child’[Mesh]) OR (‘Infant’[Mesh] OR ‘Infant
Nutrition Disorders’[Mesh])) OR ‘Child,
Preschool’[Mesh])) OR (‘Paediatric Nursing’[Mesh])))
OR (((((((((((young*)) OR (youth*)) OR (infan*)) OR
(juvenil*)) OR (child*)) OR (teen*)) OR (nurs*)) OR
(baby*))) OR (paediatric*)).
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analysed according to healthcare components (e.g. hospital
costs, physicians costs, drug prescriptions, primary and
secondary care visits, and emergency and admission),
methods (e.g. annual amount, amount trend and per-capita
costs) and time frame.
Results
Literature search results
Figure 1 illustrates the literature search and selection
process. The search strategy yielded 3,844 potentially rel-
evant articles. After removing duplicates (n = 262), 3,381
studies were excluded via title-screening because they did
not focus on CO (n = 951) or economics (n = 2,430). By
reviewing abstracts, 156 out of the 201 papers were
excluded because they did not meet the inclusion criteria,
the remaining 45 studies were included, 16 more studies
were obtained by searching ‘Related citations’ on Pubmed
and 14 studies were added after reviewing references, thus
making a total of 75 articles.
From these 75 studies, 65 papers were rejected because
they failed to meet inclusion criteria. At the end of the
process, 10 COI analyses (1–10) were considered in the
current review (Fig. 1). The features of the included studies
are reported in Table 2.
General overview
Eight COI analyses were conducted in the USA (11,12,17–
22), one in Canada (23) and one in Ireland (24). Most
studies focused on the costs of CO by exploring the direct
CINAHL 
(n = 322)
Pubmed 
(n = 3,231)
Health 
business
(n = 37)
HTA  
(n = 11)
NHS EED
(n =  96)
PsycoINFO 
(n = 5)
Cochrane  
(n = 125)
EconLit 
(n = 174)
Articles excluded on Title review: 
(n = 3,381)
Main causes for exclusion: 
•  No obesity; 
•  No population; 
•  No costs analysis; 
•  No developed countries. 
Articles excluded on abstract review: 
(n = 156)
Main causes for exclusion: 
•  No obesity (11); 
•  No population (32); 
•  No cost analysis (90); 
•  No abstract (23). 
Articles included from the 
overall keyword search
process 
(n = 45)
Articles included by 
reviewing abstracts 
(n = 201)
Articles included from the 
overall search strategy 
(n = 75) Articles excluded on full-text review: 
(n = 65)
Main causes for exclusion: 
•  No outcome (37); 
•  Full economic evaluation (16); 
•  No population (12). 
Articles included and 
analysed 
(n = 10)
Articles included by reviewing 
‘related citations’ on Pubmed
of retrieval articles 
(n = 16) 
Articles included by reviewing 
bibliographies of retrieval 
studies 
(n = 14)
Keywords search 
(n = 3,844)
Articles identified by 
searching for keyword 
included for detailed 
evaluation 
(n = 3,582)
Duplicate articles 
(n = 262)
Figure 1 Study selection process. CINAHL, Cumulative Index to Nursing and Allied Health Literature; HTA, Health Technology Assessment Database;
NHS EED, Economic Evaluation Database.
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effects of obesity-related conditions such as hypertension
(22), diabetes (17) and sleep apnea (17). Seven studies
(12,17,18,20,21,23,24) were conducted from the health-
care system perspective, considering only direct medical
costs; two studies (19,22) were conducted from the per-
spective of the third-party payer and only one analysis (11)
considered the government point of view. All studies
followed a prevalence-based approach, dealing with all
medical and morbidity costs within the study period. None
of the studies calculated CO costs by applying an incidence-
based approach.
In six papers (12,17,19–21,24), a ‘top-down’ approach
was used to estimate the economic burden related to CO
(i.e. hospital admissions and other disease-related costs). In
three studies (11,18,22), an econometric approach was
used to calculate incremental costs between the cohorts of
obese and non-obese children. Only one study (23) fol-
lowed a bottom-up approach to estimate the costs by cal-
culating the average outpatient costs of CO.
Two of the COI studies (23,24) were conducted within
a ‘Beveridge’ healthcare system (free-of-charge health
services with mainly public providers), eight studies
(11,12,17–22) within a ‘voluntary health insurance’ model
(with mostly private, largely employer-based and out-of-
pocket funding). None were conducted within a ‘Bismarck’
model (social assurance system with a statutory third-party
payer).
Each included study was categorized according to the
vertical integration of the healthcare system in which it was
placed, in other words the arrangement whereby each
healthcare system can offer, either directly or through
others, a broad range of care and support services (Table 2).
Three studies (19,23,24) estimated direct medical costs
of CO in healthcare systems characterized by a high level of
integration among revenue collection, financing, purchas-
ing and provision function. Seven studies conducted in the
USA (11,12,17,18,20–22) estimated the economic impact
of CO in healthcare systems belonging to a low level of
vertical integration.
The economic burden in terms of direct medical costs
was reported in each study. Six of the 10 studies considered
in-patient costs (11,12,21,24), four studies estimated
outpatient and primary care costs (11,19,21,23), and
seven out of 10 studies considered pharmaceutical
costs (11,12,17,20–24). Allied healthcare costs were not
included.
Unfortunately, it was not possible to compare the magni-
tude of CO healthcare costs according to different health-
care models, as the two studies that referred to the
‘Beveridge model’ applied different healthcare cost compo-
nents (average physicians costs, 23), measures and time
periods (total amount of annual hospital expenses in 1997
and in 2004, 24) than those of the eight studies referring to
‘voluntary health insurance’ models (11,12,17–22).
Publicly funded health care
Two studies considering the impact of CO on direct health-
care costs were targeted on publicly funded healthcare
systems (23,24). The COI from Ireland estimated the length
of stay and hospital costs associated with obesity and
related conditions for children between 6 and 17 years of
age (24). One study from Ontario, Canada, estimated
medical care costs in adolescents at the individual level
(23).
Regarding in-patient costs, Vellinga et al. demonstrated
that in Ireland the attributable length of stay (number of
days in hospital for CO-related conditions per 1,000 d of
hospital care) increased from 1.47 in 1997 to 4.16 in 2004.
Furthermore, the annual hospital cost was calculated to be
4.4 million Euros in 1997, increasing to 13.3 million euros
in 2004 (24).
The study conducted in Ontario by Janssen et al. found
that the average physician costs were comparable in
normal-weight and overweight/obese adolescents ($233 per
year in both groups) (23).
Privately funded health care
All the studies based on privately funded health care came
from the USA (11,12,17–22).
Four of the eight studies specifically focused on hospi-
talization and in-patient physician costs due to CO
(12,17,20,21), two focused on outpatient and primary care
costs (11,19) and the remaining two estimated prescription
drug expenditures associated with the care of CO (18,22).
Two papers analysed outpatient costs. Trasande con-
sidered the following cost categories in 2002–2005: out-
patient visits, emergency visits, office-based outpatient
service, diagnostic and laboratory services, emergency
visits, in-patient, and total number of in-patient days per
episode. Trasande found that obese children had higher
costs in the following categories: outpatient visits ($194),
prescription drugs ($114) and emergency room visits ($12).
The results also highlighted the fact that the overall US
annual cost of CO was $14.1 billion and that obese chil-
dren had 79 higher outpatient visit expenditures than
healthy children (corresponding to 47% of the total cost
for CO) (11). In the other outpatient COI, Estabrooks
analysed the costs of extra visits in a sample of 1,000
overweight children, reported an annual overall cost of
$42,148 and $31,866 for primary care sick visits and
mental health visits, respectively (19).
Quality appraisal
All studies stated the research question within the study
design (Table 1, item 1). In seven studies, the economic
importance of the research was also stated (item 2)
(11,12,18–20,22,24). Four studies did not report resources
and costs separately (item 16) (11,19,20,22), and methods
for the estimation of resource quantities and unit costs
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(item 17) were described in only three studies (18,21,22).
Currency and prices were recorded in all studies (item 18),
but details of adjustment for inflation or currency conver-
sion (item 19) were explained in only two studies (11,12).
Time horizon of analyses was well described in all studies
(item 22), and discount rates were stated (item 23);
however, the choice of rates was not justified in any of the
studies (item 24). No study gave an explanation if costs
were not discounted (item 25). In addition, only three
studies explained their approach to sensitivity analysis
(item 27), thus justifying the choice of variables used (item
28) (18,20,22). In all studies, an answer to the study ques-
tion was given (item 33), conclusions followed by the data
were reported (item 34), and caveats were discussed (item
35). According to Drummond’s checklist, the average
quality of the analyses included in our review is medium
because most studies do not give a real answer to all items.
Discussion
Obesity is of great importance from a health-policy per-
spective because of its prevalence in the population and the
costs of treating the associated medical conditions in both
the short and long term. Until recently, studies for children
and adolescents were lacking, possibly due to the assump-
tion that obesity-related health problems would occur only
after longer periods of exposure and the latency effect. This
view has been challenged by a number of studies, although
not all findings were statistically significant and applicable
to the whole child population (25).
As previous studies analysed the literature on COI
related to CO (25), our review is the first to perform a
systematic search and quality appraisal of literature and to
investigate a possible relationship between magnitude of
COI related to CO and healthcare models.
In spite of a starting number of 3,844 abstracts that fit
the search strategy, only 10 were included into our review.
We found only two studies reporting the burden of CO in
national health systems. The lack of evidence confirms that
in this priority area, more studies are required to properly
inform and advise policy and allocate resources, in order to
improve health and prevent illness.
Most studies (eight out of 10) were conducted in the
USA, where research in health issues is likely to be more
oriented to the burden of disease (26).
Our analysis points out the significance of CO healthcare-
related costs and emphasizes the need for political agendas
to focus on early intervention, through health promotion
and primary prevention of obesity. Unfortunately, the het-
erogeneity of the healthcare components,methods and time-
frame analysed by the selected studies does not permit us to
highlight possible relationships between the magnitude of
CO-related healthcare costs and alternative healthcare
systems. This issue confirms what has been stated on COI
studies, where estimates of the healthcare costs of obesity
vary depending on the method of calculation (27). For the
same reason, it was not possible to find evidence of the
differences between healthcare systems with regard to ver-
tical integration. Our results point to a need for more
comparable research, especially considering the fact that
even the diseases that are included as being attributable to
obesity differ in the available studies (27).
As for the quality appraisal of the included studies, we
found out the following points.
Regarding the section ‘Study design’, most of the studies
met the overall quality standards (i.e. statement and justi-
fication of the research question, of its economic relevance
and of the analysis viewpoints). On the other hand, we
found a lower quality level in the other two assessment
section according to Drummond’s: ‘Data collection’ and
‘Analysis and interpretation of results’. For example, no
study fully satisfied the following items: statement of the
discount rate, justification of choices of rates and explana-
tion of not discounting costs. Furthermore, just three
studies stated the approach of sensitivity analysis, and gave
the justification of variable selection.
This review is limited as a relatively small number of
published COI exist in this field. It is also open to publica-
tion bias, as we have only included the published articles.
Most of the research designs were unable to recognize with
confidence that obesity is the underlying cause of higher
costs. For example, in the cross-sectional studies and
cohort analyses that relied on one measure of weight, it was
possible that a third unobservable factor, such as an injury
or mental health condition, might have caused both
increased absences and increased weight (28). Estimates of
COI could be influenced by the selection of obesity-related
medical conditions as well as the double-counting of total
costs of diseases that are complicated by comorbidities. No
studies considered the long-term effects of CO, but concen-
trated on the short-term consequences, this is an area that
requires future research.
‘Costing’ of an illness ought to be achieved through
prevalence-based and incidence-based approaches.
Prevalence-based COI studies do not quantify the long-
term consequences of such chronic conditions as obesity in
children. Therefore, an incidence-based COI assessment
would be more appropriate (29). Nevertheless, we found
no studies combining either approach, so to focus both on
direct and indirect costs.
In pharmacoeconomic studies costs are classified into
three categories: direct costs, indirect costs, intangible costs
(27). However, none of the studies considered all three
categories.
COI studies deal with diseases and not with inter-
ventions, as cost-effectiveness and cost-benefit studies do.
So, they could demonstrate which diseases may require
increased use of resources for prevention or treatment, but
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they encounter limitations in determining how to allocate
resources and risk being overly heterogeneous in applied
methods (30). Our analysis confirms such limitations.
COI analyses have been useful in some respects to con-
ceptualize the magnitude of the CO epidemic, but do not
represent a unique tool for successful guidance of policy
in obesity-prevention. Nevertheless, COI studies would
support the policymaking process by measuring the eco-
nomic burden of a disease or diseases and estimating the
maximum amount of money that could potentially be
saved if a disease was prevented. Knowledge of the costs of
an illness can help policymakers in deciding which diseases
need to be addressed first by health care and prevention
policies and how to allocate resources in the healthcare
sector.
Based on the previous considerations:
1. there is an urgent need to intensify public health strat-
egies, because of the growing prevalence of obesity and the
related increasing economic burden. To achieve sustainable
improvements in health and limit the growth of healthcare
expenditures, decision-makers must recognize that positive
lifestyles, behaviours, and social policy factors are the
greatest factors in determining overall population health
status (31).
2. Research in this field should be intensified, offering
more comparable studies and studies of a wider range of
health systems, in order to adequately inform decision-
makers and help them to formulate rational approaches
to CO.
3. Rigorous economic evaluations and reviews would
play an important role in such a direction and should take
into account the following issues:
- to consider the long-term effects of obesity in child-
hood – not only the short-term consequences;
- to use individual data instead of census data stored
at national level in order to classify the ‘exposure’ (i.e.
BMI, weight) and the ‘effects’ (prevalence/incidence of
obesity-correlated diseases and costs, respectively), and
to adjust for confounders through the adoption of regres-
sion models.
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